Thomas W. Chalberg serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Thomas W. Chalberg has executed 10 insider transactions totaling $6.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 10, 2015 involved selling 6,995 shares valued at $272.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 10, 2015 | [AAVL] | $272.1K | Sale | 6,995 | $38.90 | Discretionary |
| Jun 10, 2015 | [AAVL] | $185.7K | Sale | 5,035 | $36.89 |
Thomas W. Chalberg currently holds 258,988 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas W. Chalberg has been a net seller of AAVL stock. They have purchased $0 and sold $6.4M worth of shares.
Thomas W. Chalberg's most recent insider trade was on Jun 10, 2015, when they sold 6,995 shares at $38.90 per share.
Get notified when new Form 4 filings are submitted
| Discretionary |
| Jun 10, 2015 | [AAVL] | $493.4K | Sale | 12,970 | $38.04 | Discretionary |
| May 5, 2015 | AAVL | $750.0K | Sale | 25,000 | $30.00 | Discretionary |
| Apr 21, 2015 | AAVL | $0 | Award | 23,000 | $N/A | Discretionary |
| Jan 13, 2015 | AAVL | $4.7M | Sale | 85,000 | $55.46 | Discretionary |
| Dec 12, 2014 | AAVL | $87 | Option Exercise | 413 | $0.21 | Discretionary |
| Dec 12, 2014 | AAVL | $0 | Gift | 413 | $N/A | Discretionary |
| Dec 12, 2014 | AAVL | $0 | Gift | 413 | $N/A | Discretionary |
| Aug 5, 2014 | AAVL | $0 | Conversion | 10,988 | $N/A | Discretionary |